Search This Blog

Wednesday, July 31, 2019

Amedisys EPS beats by $0.22, beats on revenue

Amedisys  (NASDAQ:AMED): Q2 Non-GAAP EPS of $1.21 beats by $0.22; GAAP EPS of $1.02 beats by $0.03.
Revenue of $492.98M (+19.8% Y/Y) beats by $3.32M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)